Compounded Oral Tirzepatide at $229: The MadeMed Format Explained

For patients who want tirzepatide's efficacy but not tirzepatide's needle, compounded oral formats have emerged in 2026 at ~$229/month. MadeMed's oral tirzepatide is one of the more visible options. Here's how the format works, what to expect, and who it fits.

What Compounded Oral Tirzepatide Actually Is

Compounded oral tirzepatide is typically prepared as an orally disintegrating tablet (ODT), sublingual troche, or oral drops. The active pharmaceutical ingredient is tirzepatide (the same molecule as brand Mounjaro/Zepbound), formulated for oral absorption instead of subcutaneous injection.

Because oral tirzepatide isn't commercially available at all — Lilly's brand tirzepatide is injectable-only — the compounded oral format meets the "meaningful difference" standard under 503A regulations more clearly than injectable compounding does. This regulatory footing is part of why oral tirzepatide compounders have faced less litigation pressure than injectable ones.

How Absorption Works

Peptide absorption through the oral mucosa or GI tract is inherently less efficient than subcutaneous injection. To compensate, oral compounded tirzepatide is typically dosed at higher milligram amounts than injectable equivalents — a 5 mg injectable dose might correspond to a substantially higher oral dose to achieve comparable blood levels.

This is why "oral tirzepatide" and "injectable tirzepatide" aren't 1:1 equivalents on paper. The formulation, absorption pathway, and dose all differ. Your prescriber will translate your intended injectable-equivalent dose to an oral compounded dose based on the specific formulation.

Who the Format Fits

Oral tirzepatide fits patients who: dislike needles strongly enough that they'd otherwise skip GLP-1 therapy entirely; travel frequently and want to avoid packing injectables through TSA and international customs; have specific needle-related medical conditions (bleeding disorders, needle phobia diagnosed as a phobic disorder); or want to stack tirzepatide with an oral supplement regimen for convenience.

It fits less well for patients who are highly cost-sensitive (injectable compounded tirzepatide is often cheaper by milligram), patients with GI absorption issues (post-bariatric surgery, active IBD), or patients who want the most efficient conversion of dose-to-effect.

The $167–$229 Range

The $167–$229/month range corresponds to different dose tiers within oral tirzepatide programs. Lower doses cost less; maintenance doses (equivalent to higher injectable strengths) cost more. When comparing to injectable pricing, run the math on your maintenance-dose cost, not the intro tier.

What to Ask Before Starting

Ask the prescriber: what's the expected steady-state dose you'll reach, and what does that cost per month? What's the pharmacy's testing protocol for oral formulations specifically (absorption is harder to verify than injectable potency)? Does the pharmacy stand behind a specific absorption profile with data? And what's the return/exchange policy if the oral format doesn't work for you within the first month?

Where to Start